Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Companies Law Companies Law + HC Companies Law - 2008 (3) TMI HC This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2008 (3) TMI 489 - HC - Companies Law


Issues Involved:
1. Whether a subsidiary of a subsidiary of a holding company can be treated as the subsidiary of the holding company.
2. Whether the activities of a wholly owned subsidiary can be treated as the activities of its holding company.
3. Allegations of suppression of material facts and making false and misleading statements by the petitioners.
4. Legality of the tender process and the selection of respondent No. 4.
5. Whether respondent No. 4 is a manufacturer of pacemakers and eligible to participate in the tender process.

Issue-wise Detailed Analysis:

1. Whether a subsidiary of a subsidiary of a holding company can be treated as the subsidiary of the holding company:
The court referred to Section 4 of the Companies Act, 1956, which clarifies that a subsidiary of a subsidiary of a holding company is considered a subsidiary of the holding company. The illustration appended to Section 4 supports this interpretation. Thus, respondent No. 4, being a wholly owned subsidiary of the Netherlands company, which is a wholly owned subsidiary of the parent American company, is deemed a subsidiary of the parent American company.

2. Whether the activities of a wholly owned subsidiary can be treated as the activities of its holding company:
The court discussed the principle of lifting the corporate veil, citing cases such as Salomon v. A. Salomon and Co. Ltd., DHN Food Distributors Ltd. v. London Borough of Tower Hamlets, and State of Uttar Pradesh v. Renusagar Power Co. The court concluded that when a subsidiary is wholly owned and controlled by its parent company, the activities of the subsidiary can be treated as those of the parent company. The NIT's stipulation that a subsidiary can supply pacemakers if it provides a lifetime warranty from the parent company further supports this view.

3. Allegations of suppression of material facts and making false and misleading statements by the petitioners:
The court found that the petitioners had suppressed material facts and made false and misleading statements. The petitioners initially claimed ignorance of the reasons for not opening the tender papers on May 28, 2007, and the subsequent date of opening. However, evidence showed that the petitioners' representative was present on May 29, 2007, when the tender papers were opened. The court concluded that the petitioners had misled the court and committed perjury.

4. Legality of the tender process and the selection of respondent No. 4:
The court examined the technical committee's findings and the specifications mentioned in the NIT. It found that the petitioner-company's offered models did not meet the required specifications, whereas respondent No. 4's product satisfied all the minimum criteria and had additional features. The selection of respondent No. 4's product was found to be in public interest, and there was no evidence of arbitrariness, irrationality, or illegality in the decision-making process.

5. Whether respondent No. 4 is a manufacturer of pacemakers and eligible to participate in the tender process:
The court considered the argument that respondent No. 4, as a wholly owned subsidiary of the parent American company, should be treated as a manufacturer of the pacemakers. The NIT allowed a subsidiary to bid if it provided a lifetime warranty from the parent company. Respondent No. 4 had submitted such a warranty. The court concluded that respondent No. 4 was eligible to participate in the tender process as a manufacturer.

Conclusion:
The writ petition was dismissed with costs of Rs. 10,000. The court found no merit in the petitioners' claims, determined that respondent No. 4 was eligible to participate in the tender process, and upheld the selection of respondent No. 4's product.

 

 

 

 

Quick Updates:Latest Updates